세계의 VNA 및 PACS 시장 : 제품 유형별, 모달리티별, 전개 유형별, 용도별, 최종 사용자별, 지역별, 기회, 예측(2017년-2031년)

Global VNA and PACS market is projected to witness a CAGR of 7.68% during the forecast period 2024-2031, growing from USD 3.87 billion in 2023 to USD 7.00 billion in 2031. Medical imaging management solutions such as Picture Archiving and Communication System (PACS) and Vendor Neutral Archive (VNA) are used to compare images of a patient or group of patients simultaneously that are taken at different time frames to gauge the disease's progression and prognosis. With the help of these technologies, physical archiving is replaced by digitally organizing and storing all medical imaging files. These solutions also make it possible to combine patient data from medical images with information from other sources, including electronic health records, radiology information systems (RIS), and health information systems. Increasing investments in medical imaging technologies, increased demand for imaging equipment, technological developments in diagnostic imaging modalities, an aging population that drives up imaging volumes, growing healthcare IT & EHR adoption, and the growth of big data presence in healthcare are some of the reasons driving this market's growth. Furthermore, there should be a lot of room for growth in the medical imaging market due to the integration of PACS/VNA with Electronic Medical Record (EMR), the introduction of artificial intelligence (AI), the growing popularity of hybrid and cloud-based medical imaging systems, and the quickly expanding telehealth sector.

For example, a vendor-neutral platform solution for echocardiography image processing and reporting, called Ultrasound Workspace, was introduced by Koninklijke Philips N.V. in March 2022 at the American College of Cardiology's Annual Scientific Session & Expo (ACC2022). It is a sophisticated vendor-neutral system for analyzing and reporting 2D and 3D echocardiograms. However, the extended product lifecycle of VNA and financial limitations limit the market's expansion. Additionally, the market's expansion is estimated to be fueled by improved data transfer and enhanced interoperability. For instance, a leading supplier of diagnostic and enterprise imaging solutions, FUJIFILM Holdings America Corporation, stated in February 2024 that their Synapse VNA and Synapse Radiology PACS were awarded the best in class at 2024 Best in KLAS Awards: Software and Services.

Surge in Digitalization of Medical Imaging Leading to Market Expansion

The way medical images are obtained, stored, and disseminated has undergone a radical change because of the digitalization of medical imaging. Along with improving patient care, this change has been a major factor in the market's drastic rise for PACS and VNA worldwide. Medical images were previously recorded on X-ray films and kept in physical archives, which came with a number of difficulties. The medical imaging industry has gone digital, meaning that film is no longer necessary. This allows medical professionals to take, store, and distribute images in electronic formats. This change has not only enhanced the quality of the images but has also simplified the management and retrieval of patient data. Electronic technologies simplify saving, retrieving, and managing digital photos. Centralized digital repositories for medical images are made available to healthcare facilities via PACS solutions, and VNAs expand this capacity to accommodate other patient data types. Effective data management improves patient care by streamlining processes and cutting down on administrative burdens. Digitalization facilitates the interoperability between various medical imaging systems and devices. PACS and VNA systems are made to work easily with diverse imaging devices made by different companies. Regardless of the source, this interoperability guarantees that medical pictures can be accessed and shared throughout the healthcare ecosystem. Healthcare practitioners can review patient data remotely from any location with an internet connection by using digital medical imaging. With telemedicine and remote consultations, where experts may give their input without being physically present, the market promises to expand further.

For example, Avicenna.AI, a medical imaging firm, in February 2023 introduced CINA-iPE, an AI tool that is CE certified and checks CT scan images of the chest for the possibility of an inadvertent pulmonary embolism. The first product in Avicenna.AI's new CINA Incidental line of medical imaging products is CINA-iPE.AI, which uses CT images to identify unknown disorders.

Growth in Market Due to Interoperability and Integration

It is now essential to have seamless access to patient data and medical imaging in the ever-changing healthcare ecosystem. The market for PACS and VNAs, which is growing significantly because of interoperability and integration, was created in response to this demand. The capacity of various systems, gadgets, and applications to easily connect and exchange data is referred to as interoperability in the healthcare industry. Regardless of the vendor or data format, interoperability in the context of VNA and PACS enables diverse healthcare systems to collaborate effectively. This is important since most imaging equipment used by healthcare organizations is multi-vendor, which means it comes from various manufacturers. These gaps are filled by interoperable PACS and VNAS, which promote effective data interchange.

While interoperability guarantees compatibility between systems, integration guarantees seamless system integration. By offering a uniform platform for viewing and managing patient data, PACS and VNA solutions that are linked with an organization's current systems, such as Radiology Information Systems (RIS) and Electronic Health Records (EHRS), expedite operations. This integration lessens the administrative load and improves operational efficiency. Data redundancy is decreased via integrated and interoperable VNA and PACS systems. These systems operate for centralized storage as an alternative to storing the same patient data or photographs in several places. This reduces the possibility of data inaccuracies and inconsistencies, which can be crucial when making decisions in the healthcare sector. It also saves storage space. Systems that are compatible, guarantee that patient data is accessible when and where it is needed. This facilitates faster access to vital medical pictures and patient histories for radiologists and physicians. In the end, timely access to thorough patient data improves patient care by facilitating quicker and more accurate diagnosis and treatment decisions. Interoperability and integration go hand in hand to facilitate better healthcare IT.

For instance, RamSoft, Inc. (Canada) introduced its imaging EMR solution, OmegaAl, in January 2024. VNA, Enterprise Imaging, PACS, RIS, streamlined image exchange/sharing, routing, and storage, a zero-footprint (ZFP) viewer, unified worklist, radiology reporting, document management, peer, patient portal, and a real-time business intelligence and analytics solution are all combined into one cloud-native, serverless imaging EMR software platform.

Increasing Dominance of On-Site (Premise) Segment Leads to Market Growth

The conventional approach of software implementation is the on-site model. For storing and managing patient data, hospitals and healthcare facilities often prefer on-premises data storage. When customers need to update their systems or switch to new technology, they use the on-site mode of delivery. Some end users or service providers choose the on-site mode of delivery since they are unfamiliar with VNA and PACS technology. Because on-premises software is becoming widely popular among service providers worldwide, it is anticipated to hold a sizable revenue share in the market under study. The on-premises delivery model offers additional protection because servers and data are physically housed in service providers' offices, allowing specialised integration with other current company systems. For example, in May 2022, Cleo Communications LLC-a cloud-based integration platform-published an article stating that on-premises software is not hosted on a vendor-supplied cloud but rather is installed and maintained internally at a physical office. The companies themselves manage these, but the systems and data are still under their control. Therefore, it is anticipated that the security associated with the mode of delivery will propel the market's segment growth. Furthermore, the segment is growing rapidly due to innovation, new product launches, and ongoing efforts by significant players. For example, ScImage, Inc., a top supplier of cloud-based enterprise imaging and reporting solutions, introduced its PICOM365 enterprise imaging process in February 2022. This PICOM365 is powered by Microsoft Azure Cloud and offers all the features of on-premises PACS software systems. Therefore, owing to the above-mentioned factors, the segment is expected to grow over the forecast period.

North America to Dominate the VNA and PACS Market

The market for Vendor-Neutral Archive (VNA) and PACS in North America is anticipated to grow profitably due to the rising desire for PAC systems to be universal, the decline in data storage prices, and the compatibility of VNA with data archive systems. In addition to these, the healthcare IT industry's well-developed infrastructure, the existence of significant companies, and the measures implemented by market participants in regions like the United States are supporting the market's expansion. Furthermore, it is anticipated that the researched markets in Canada and Mexico will expand during the period. The market is expected to increase because of product launches and collaborations between national service providers and market participants.

For example, a Mexican platform called Eva, LLC expanded digital diagnostics throughout Latin America in January 2022, allowing remote test analysis and extending healthcare access outside of major cities. This platform offers affordable, digital substitutes for traditional imaging plates, expediting the diagnostic procedure. Enlarging and rotating images facilitates improved interpretation and analysis. Its services, which digitise the diagnostic procedure, are far less expensive than physical imaging plates. Additionally, Sectra AB and North York General Hospital (NYGH) in Canada signed a contract in April 2022. NYGH would examine and archive images using Sectra's enterprise imaging solution's radiology and breast imaging modules as well as VNA. By doing more without adding to the stress on staff, NYGH will be able to improve patient care by boosting the efficiency of radiological reading and streamlining present procedures. Therefore, market expansion in North America is anticipated to be driven by the advancements in each of the region's member states.

Future Market Scenario (2024-2031F)

Main factors contributing to the anticipated growth of VNA and PACS market are the rising geriatric population and the increasing instances of chronic diseases that lead to increased volumes of diagnostic imaging. However, growing big data presence in healthcare, and growing healthcare IT & EHR adoption are also going to fuel the market growth in future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an un-paralleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion.

For instance, in April 2022, to standardise the digital imaging networks' picture archiving and communication systems (DIN-PACS) for ten years at US Navy and Air Force medical treatment facilities, the US Department of Defence (DoD) and Fujifilm Holdings America Corporation worked together on the Synapse PACS solutions.

Key Players Landscape and Outlook

Major players operating in the market are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed VNA and PACS solutions to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, to improve imaging operations, InsiteOne (US) announced in November 2023 that it would purchase BRIT Systems, Inc.'s cloud-native RIS/PACS/VNA system. The goal of this acquisition would be to create low-cost solutions that raise operational efficiency and improve patient care.

Similarly, to provide digital pathology departmental solutions that give healthcare providers a thorough understanding of patient records, GE HealthCare Technologies Inc. (US) and Tribun Health (Paris) partnered in November 2022. The goal of this collaboration was to integrate Tribun's Health Suite data with GE Healthcare Technologies Inc.'s solutions, including its vendor-neutral archive (VNA) solution portfolio.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global VNA and PACS Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. VNA
    • 4.2.1.2. PACS
  • 4.2.2. By Modality
    • 4.2.2.1. CT scans
    • 4.2.2.2. MRI scans
    • 4.2.2.3. Ultrasounds
    • 4.2.2.4. X-rays
    • 4.2.2.5. Others
  • 4.2.3. By Deployment Type
    • 4.2.3.1. On-Site Model
    • 4.2.3.2. Cloud-Based Model
    • 4.2.3.3. Hybrid Model
  • 4.2.4. By Application
    • 4.2.4.1. Cardiology
    • 4.2.4.2. Oncology
    • 4.2.4.3. Radiology
    • 4.2.4.4. Neurology
    • 4.2.4.5. Pathology
    • 4.2.4.6. Others
  • 4.2.5. By End-user
    • 4.2.5.1. Hospitals and Clinics
    • 4.2.5.2. Diagnostic Centres
    • 4.2.5.3. Ambulatory Surgical Centres
    • 4.2.5.4. Others
  • 4.2.6. By Region
    • 4.2.6.1. North America
    • 4.2.6.2. Europe
    • 4.2.6.3. Asia-Pacific
    • 4.2.6.4. South America
    • 4.2.6.5. Middle East and Africa
  • 4.2.7. By Company Market Share (%), 2023
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product Type
  • 4.3.2. By Modality
  • 4.3.3. By Deployment Type
  • 4.3.4. By Application
  • 4.3.5. By End-user
  • 4.3.6. By Region

5. North America VNA and PACS Market Outlook, 2017-2031F*

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. VNA
    • 5.2.1.2. PACS
  • 5.2.2. By Modality
    • 5.2.2.1. CT scans
    • 5.2.2.2. MRI scans
    • 5.2.2.3. Ultrasounds
    • 5.2.2.4. X-rays
    • 5.2.2.5. Others
  • 5.2.3. By Deployment Type
    • 5.2.3.1. On-Site Model
    • 5.2.3.2. Cloud-Based Model
    • 5.2.3.3. Hybrid Model
  • 5.2.4. By Application
    • 5.2.4.1. Cardiology
    • 5.2.4.2. Oncology
    • 5.2.4.3. Radiology
    • 5.2.4.4. Neurology
    • 5.2.4.5. Pathology
    • 5.2.4.6. Others
  • 5.2.5. By End-user
    • 5.2.5.1. Hospitals and Clinics
    • 5.2.5.2. Diagnostic Centres
    • 5.2.5.3. Ambulatory Surgical Centres
    • 5.2.5.4. Others
  • 5.2.6. By Country Share
    • 5.2.6.1. United States
    • 5.2.6.2. Canada
    • 5.2.6.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States VNA and PACS Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
        • 5.3.1.2.1.1. VNA
        • 5.3.1.2.1.2. PACS
      • 5.3.1.2.2. By Modality
        • 5.3.1.2.2.1. CT scans
        • 5.3.1.2.2.2. MRI scans
        • 5.3.1.2.2.3. Ultrasounds
        • 5.3.1.2.2.4. X-rays
        • 5.3.1.2.2.5. Others
      • 5.3.1.2.3. By Deployment Type
        • 5.3.1.2.3.1. On-Site Model
        • 5.3.1.2.3.2. Cloud-Based Model
        • 5.3.1.2.3.3. Hybrid Model
      • 5.3.1.2.4. By Application
        • 5.3.1.2.4.1. Cardiology
        • 5.3.1.2.4.2. Oncology
        • 5.3.1.2.4.3. Radiology
        • 5.3.1.2.4.4. Neurology
        • 5.3.1.2.4.5. Pathology
        • 5.3.1.2.4.6. Others
      • 5.3.1.2.5. By End-user
        • 5.3.1.2.5.1. Hospitals and Clinics
        • 5.3.1.2.5.2. Diagnostic Centres
        • 5.3.1.2.5.3. Ambulatory Surgical Centres
        • 5.3.1.2.5.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe VNA and PACS Market Outlook, 2017-2031F

• 6.1.1. Germany
• 6.1.2. France
• 6.1.3. Italy
• 6.1.4. United Kingdom
• 6.1.5. Russia
• 6.1.6. Netherlands
• 6.1.7. Spain
• 6.1.8. Turkey
• 6.1.9. Poland

7. Asia-Pacific VNA and PACS Market Outlook, 2017-2031F

• 7.1.1. India
• 7.1.2. China
• 7.1.3. Japan
• 7.1.4. Australia
• 7.1.5. Vietnam
• 7.1.6. South Korea
• 7.1.7. Indonesia
• 7.1.8. Philippines

8. South America VNA and PACS Market Outlook, 2017-2031F

• 8.1.1. Brazil
• 8.1.2. Argentina

9. Middle East and Africa VNA and PACS Market Outlook, 2017-2031F

• 9.1.1. Saudi Arabia
• 9.1.2. UAE
• 9.1.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Koninklijke Philips N.V.
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 21.3.2. FUJIFILM Holdings America Corporation
  • 21.3.3. GE HealthCare Technologies Inc.
  • 21.3.4. Siemens Healthcare Private Limited
  • 21.3.5. ScImage, Inc.
  • 21.3.6. Sectra AB
  • 21.3.7. RamSoft, Inc.
  • 21.3.8. Avicenna.AI
  • 21.3.9. Canon Medical Systems Corporation
  • 21.3.10. Hyland Software, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer